The agency announced plans to study the adverse affects of the eye surgery Thursday.
Washington (WiredPRNews.com) – The Food and Drug Administration (FDA) is set to study the range of issues that have been linked to Lasik eye surgery. As reported by the Associated Press (AP), the agency announced its plans this week citing the effort to assess the number of patients who exhibit adverse reactions following the procedure.
As noted by the AP, the agency will work with National Eye Institute and the Department of Defense on the project. Dr. Jeffrey Shuren, the FDA’s medical device division acting head, is quoted in the report as stating of the study, “This study will enhance our understanding of the risks of Lasik and could lead to a reduction in patients who experience adverse effects.”
As further noted by the AP, more than six million people have undergone the Lasik procedure in the country, yet relatively little is known about its safety long-term.
WiredPRNews.com – The latest in Health News
Photo Credit: Wikipedia User Raul654